Search filters

List of works by Bernard A Fox

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

scientific article published on 8 December 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

scientific article published on 19 December 2017

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".

scientific article

Active-specific immunotherapy for non-small cell lung cancer ⬇️

scientific article published on June 1, 2011

Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy

scientific article published on 18 December 2018

Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses

scientific article published on April 2003

Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response

scientific article

Adoptive TIL in HPV-negative oral scca.

scientific article published on 4 November 2015

Adoptive cellular immunotherapy of cancer: a three-signal paradigm for translating recent developments into improved treatment strategies.

scientific article

Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cells

scientific article published on 01 July 2002

Allogeneic breast cancer cell vaccines.

scientific article

An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers

scientific article published on 4 November 2015

An image analysis algorithm based on the hue saturation density transformation, an important tool for melanoma immunotherapy research.

scientific article published on 6 November 2014

Announcing the tumor immunology and biological cancer therapy section (edited by iSBTc) of the Journal of Translational Medicine

scientific article published on 17 September 2009

Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution

scientific article published in August 2003

Assessment of the tumor immune-environment in patients with head and neck cancer.

scientific article published on 4 November 2015

Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer

scientific article published on 25 September 2018

Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPs

scientific article published on September 2012

Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans

scientific article published on 29 March 2007

CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells

scientific article published on 01 November 2002

Cancer and inflammation: promise for biologic therapy.

scientific article

Cancer classification using the Immunoscore: a worldwide task force

scientific article

Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects.

scientific article

Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response?

scientific article published on 9 June 2006

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies.

scientific article published on 6 November 2014

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

scientific article published in 2022

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors

scientific article published in Nature Communications

Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression

scientific article

Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model

scientific article

Comparison of proteomic and genomic analyses of vaccine cell lines shows men receiving prostate gvax immunotherapy develop increased humoral responses to common cell line proteins relative to mutated proteins

scientific article published on 6 November 2014

Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination

scientific article published on 5 April 2018

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

scientific article published on 04 July 2019

Correction: Multispectral Imaging of T and B Cells in Murine Spleen and Tumor

scientific article published in February 2017

Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease

scientific article published on 15 February 2018

Counteracting breast-cancer induced immune suppression by reactivating lymph node-resident conventional dendritic cells (LNR-cDC).

scientific article published on 4 November 2015

Cross-presentation of tumor associated antigens through tumor-derived autophagosomes

scientific article

Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells

scientific article

Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus-negative oral squamous cell carcinomas with negative resection margins

scientific article published on 23 October 2020

Current immunotherapeutic strategies in lung cancer

scientific article published on October 2007

Cytomegalovirus containing TRP2 antigen provides protective immunity against the poorly immunogenic B16BL6-D5 melanoma

scientific article published on 7 November 2013

Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy

scientific article published on 7 September 2016

DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9.

scientific article published on 7 November 2013

Defining the critical hurdles in cancer immunotherapy

scientific article published on 14 December 2011

Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts

scientific article

Developing an Immunotherapy Strategy for the Effective Treatment of Oral, Head and Neck Squamous Cell Carcinoma.

scientific article

Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck.

scientific article published on 7 November 2013

Development of antitumor immune responses in reconstituted lymphopenic hosts.

scientific article published in July 2002

Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity.

scientific article

Editorial: Advances in Combination Tumor Immunotherapy

scientific article

Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity

scientific article published on 15 April 2020

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology

scientific article

Erratum to 'Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy' [Oral Oncol. 61 (2016) 166-176].

scientific article

Evaluation of circulating tumor cell gene expression profiles before and following combination immunotherapy for advanced prostate cancer

scientific article published on 6 November 2014

Focus on the target: the tumor microenvironment, Society for Immunotherapy of Cancer Annual Meeting Workshop, October 24th-25th 2012.

scientific article published on 27 June 2013

Future Research Goals in Immunotherapy

scientific article published on 12 April 2019

Future of cancer vaccines

scientific article published on January 2014

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

scientific article

Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".

scientific article published on 3 June 2013

Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010"

scientific article published on 26 March 2011

Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011".

scientific article published on 4 July 2012

Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine

scientific article

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer

scientific article published in February 2004

Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10 ⬇️

scientific article published on 01 May 2020

Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion

scientific article published on 16 December 2016

Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells

scientific article published on March 2003

Immune Monitoring Technology Primer: protein microarray ('seromics')

scientific article

Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials

scientific article

Immunological monitoring of patients with melanoma after peptide vaccination using soluble peptide/HLA-A2 dimer complexes

scientific article published on January 2004

Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challenges

scientific article published on 18 February 2017

Immunotherapy biomarkers 2016: overcoming the barriers.

scientific article published on 21 March 2017

Immunotherapy for melanoma: the good, the bad, and the future

scientific article

Immunotherapy of cancer: key findings and commentary on the third Tegernsee conference

scientific article published on 8 January 2010

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.

scientific article published in December 2016

Immunotherapy of lung cancer: an update

scientific article

Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence

scientific article published on 20 June 2012

Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion protein

scientific article published on January 2008

Induction of circulating tumor-reactive CD8+ T cells after vaccination of melanoma patients with the gp100 209-2M peptide

scientific article

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

scientific article published on 01 April 2020

Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.

scientific article

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

scientific article published in The Lancet

Lean oncology: a new model for oncologists

scientific article published on 25 April 2012

MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection

scientific article published on 10 January 2018

MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab.

scientific article published on 6 May 2014

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

scientific article published on 08 September 2020

Multiparametric immune profiling in HPV- oral squamous cell cancer

scientific article published on 20 July 2017

Multiple vaccinations: friend or foe.

scientific article published on September 2011

Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune Cells

scientific article published on 01 January 2019

Multispectral Imaging of T and B Cells in Murine Spleen and Tumor.

scientific article published on 18 March 2016

Multispectral imaging and objective assessment of immune-tumor interactions in non-small cell lung cancer.

scientific article published on 4 November 2015

Multispectral imaging of T and B cells in murine tissue.

scientific article published on 4 November 2015

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma

scientific article

New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay

scientific article published on 4 November 2015

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study

scientific article published on 13 October 2020

Novel frontiers in detecting cancer metastasis

scientific article published on 18 July 2018

Novel strategy to monitor apparent tumor-specific T cells in patients with cancer

scientific article published on 7 November 2013

Novel technologies and emerging biomarkers for personalized cancer immunotherapy

scientific article

OX40 is a potent immune-stimulating target in late-stage cancer patients

scientific article

OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironment

scientific article

OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer

scientific article published on 15 April 2016

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy

scientific article

PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab

scientific article published on 05 September 2018

Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy.

scientific article

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy)

scientific article published on 29 November 2019

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).

scientific article published on 11 July 2018

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, December 5th 2015.

scientific article published on 18 October 2016

Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)

scientific article published on 07 September 2020

Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer

scientific article published on 04 July 2019

Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

scientific article published on 06 May 2020

Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment.

scientific article published on 4 November 2015

Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization

scientific article published on August 2008

Preamble to the 2015 SITC immunotherapy biomarkers taskforce

scientific article

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC.

scientific article published on 6 November 2014

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC.

scientific article published on 4 November 2015

Profiling of suppressive immune subsets in metastasis negative and positive sentinel lymph nodes from patients with HER2- breast cancer.

scientific article published on 6 November 2014

Pyruvate kinase M2 may be a therapeutic target in a mouse model of human non-small cell lung cancer.

scientific article published on 4 November 2015

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

scientific article

Reduced L-selectin (CD62LLow) expression identifies tumor-specific type 1 T cells from lymph nodes draining an autologous tumor cell vaccine

scientific article

Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cells

scientific article published on February 2003

Regression of bone metastases following adoptive transfer of anti-CD3-activated and IL-2-expanded tumor vaccine draining lymph node cells

scientific article published on 01 January 2004

Relationships matter in oral cancer: will single-stain immunohistochemistry become irrelevant in the age of multispectral imaging?

scientific article published on 28 September 2017

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art

scholarly article by Lisa H Butterfield et al published 4 December 2018 in Journal for Immunotherapy of Cancer

SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery

scientific article

STING expression and response to treatment with STING ligands in premalignant and malignant disease

scientific article published on 14 November 2017

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab

scientific article published on 4 November 2015

Signaling through OX40 enhances antitumor immunity

scientific article published on October 2010

Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer

scientific article published on 23 May 2019

Supporting the advancement of science: Open access publishing and the role of mandates ⬇️

scientific article published on January 24, 2012

Sustained complete response to CTLA-4 blockade in a patient with metastatic, castration-resistant prostate cancer

scientific article published on 3 February 2014

TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cells

scientific article published on February 2003

Targeting and amplification of immune killing of tumor cells by pro-Smac

scientific article published on March 2004

The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes

scientific article published on 03 July 2018

The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response

scientific article published on 01 May 2020

The State of Melanoma: Emergent Challenges and Opportunities

scientific article published on 07 January 2021

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment

scientific article published on 3 March 2013

The immune score as a new possible approach for the classification of cancer

scientific article published on 3 January 2012

The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

scientific article published on 3 November 2017

Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines

scientific article

Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40.

scientific article published on 28 August 2017

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

scientific article published on 22 May 2019

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

scientific article

Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1

scientific article published on 18 December 2018

Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism ⬇️

scientific article published on August 2, 2011

Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy ⬇️

scientific article published on November 8, 2011

Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells

scientific article

Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptor

scientific article published on 13 March 2007

Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studies

scientific article published in March 2003

Ubiquitinated Proteins Isolated From Tumor Cells Are Efficient Substrates for Antigen Cross-Presentation

scientific article

Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients

scientific article published on 6 November 2014

Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results

scientific article published on 01 July 2003

Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients

[Mechanism of augmented anti-tumor immunity in reconstituted lymphopenic mice immunized with melanoma vaccine]

scientific article published on 01 December 2005

[New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine]

scientific article published on 01 August 2005

gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells

scientific article published on January 2004

Paulina is supported by:

About Paulina

Help